Daiichi Sankyo divests Sun Pharma stake

The Japanese pharmaceuticals giant has finally exited from its troubled foray into India by selling its entire stake in Sun Pharmaceuticals for $3.2 billion.

Daiichi Sankyo divests Sun Pharma stake

Japanese pharmaceuticals giant Daiichi Sankyo has raised Rs201.46 billion $3.2 billion from the sale of its entire 8.9% stake in Sun Pharmaceuticals, closing the book on its ill-fated foray into India. 

Daiichi Sankyo bought a 63.4% stake in Ranbaxy Laboratories for $4.6 billion in 2008 but was shortly afterwards hit by FDA sanctions and fines for poor product safety controls at the Indian company. 

The Japanese company...

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition


  • 2nd Compliance Summit Southeast Asia

    17 August 2017  |  Singapore
    The 2017 Compliance Summit Southeast Asia will take an in-depth look at the key compliance considerations today with a focus on regulation and new ...